These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28940199)

  • 1. Expanding the phenotype of DNAJC3 mutations: A case with hypothyroidism additionally to diabetes mellitus and multisystemic neurodegeneration.
    Bublitz SK; Alhaddad B; Synofzik M; Kuhl V; Lindner A; Freiberg C; Schmidt H; Strom TM; Haack TB; Deschauer M
    Clin Genet; 2017 Nov; 92(5):561-562. PubMed ID: 28940199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of BiP co-chaperone DNAJC3 causes diabetes mellitus and multisystemic neurodegeneration.
    Synofzik M; Haack TB; Kopajtich R; Gorza M; Rapaport D; Greiner M; Schönfeld C; Freiberg C; Schorr S; Holl RW; Gonzalez MA; Fritsche A; Fallier-Becker P; Zimmermann R; Strom TM; Meitinger T; Züchner S; Schüle R; Schöls L; Prokisch H
    Am J Hum Genet; 2014 Dec; 95(6):689-97. PubMed ID: 25466870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Homozygous
    Alwatban S; Alfaraidi H; Alosaimi A; Alluhaydan I; Alfadhel M; Polak M; Almutair A
    Front Endocrinol (Lausanne); 2021; 12():742278. PubMed ID: 34630333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAJC3 deficiency induces β-cell mitochondrial apoptosis and causes syndromic young-onset diabetes.
    Lytrivi M; Senée V; Salpea P; Fantuzzi F; Philippi A; Abdulkarim B; Sawatani T; Marín-Cañas S; Pachera N; Degavre A; Singh P; Derbois C; Lechner D; Ladrière L; Igoillo-Esteve M; Cosentino C; Marselli L; Deleuze JF; Marchetti P; Eizirik DL; Nicolino M; Chaussenot A; Julier C; Cnop M
    Eur J Endocrinol; 2021 Mar; 184(3):455-468. PubMed ID: 33486469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into diabetes mellitus due to DNAJC3-defect: Evolution of neurological and endocrine phenotype in the pediatric age group.
    Ozon ZA; Alikasifoglu A; Kandemir N; Aydin B; Gonc EN; Karaosmanoglu B; Celik NB; Eroglu-Ertugrul NG; Taskiran EZ; Haliloglu G; Oguz KK; Kiper PO; Yalnizoglu D; Utine GE; Alikasifoglu M
    Pediatr Diabetes; 2020 Nov; 21(7):1176-1182. PubMed ID: 32738013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAJC3 mutation in Thai familial type 2 diabetes mellitus.
    Kulanuwat S; Tangjittipokin W; Jungtrakoon P; Chanprasert C; Sujjitjoon J; Binnima N; Yenchitsomanus PT; Plengvidhya N
    Int J Mol Med; 2018 Aug; 42(2):1064-1073. PubMed ID: 29767246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic DNAJC3 variants in a neuroendocrine developmental disorder with insulin dysregulation.
    Ocansey S; Pullen D; Atkinson P; Clarke A; Hadonou M; Crosby C; Short J; Lloyd IC; Smedley D; Assunta A; Shah P; McEntagart M;
    Clin Dysmorphol; 2022 Jan; 31(1):11-17. PubMed ID: 34654017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of GLIS3 in thyroid disease as part of a multisystem disorder.
    Dimitri P
    Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):175-182. PubMed ID: 28648506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended clinical features associated with novel Glis3 mutation: a case report.
    Alghamdi KA; Alsaedi AB; Aljasser A; Altawil A; Kamal NM
    BMC Endocr Disord; 2017 Mar; 17(1):14. PubMed ID: 28253873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel GLIS3 mutations demonstrate an extended multisystem phenotype.
    Dimitri P; Warner JT; Minton JA; Patch AM; Ellard S; Hattersley AT; Barr S; Hawkes D; Wales JK; Gregory JW
    Eur J Endocrinol; 2011 Mar; 164(3):437-43. PubMed ID: 21139041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Neonatal diabetes mellitus with congenital hypothyroidism as a result of biallelic heterozygous mutations in GLIS3 gene.
    Perdas E; Gadzalska K; Hrytsiuk I; Borowiec M; Fendler W; Młynarski W
    Pediatr Diabetes; 2022 Sep; 23(6):668-674. PubMed ID: 35394098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.
    Senée V; Chelala C; Duchatelet S; Feng D; Blanc H; Cossec JC; Charon C; Nicolino M; Boileau P; Cavener DR; Bougnères P; Taha D; Julier C
    Nat Genet; 2006 Jun; 38(6):682-7. PubMed ID: 16715098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variation among four family members with congenital hypothyroidism caused by two distinct thyroglobulin gene mutations.
    Pardo V; Rubio IG; Knobel M; Aguiar-Oliveira MH; Santos MM; Gomes SA; Oliveira CR; Targovnik HM; Medeiros-Neto G
    Thyroid; 2008 Jul; 18(7):783-6. PubMed ID: 18631008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital goitre with hypothyroidism caused by a novel compound heterozygous mutations in the thyroglobulin gene.
    Targovnik HM; Souchon PF; Machiavelli GA; Salmon-Musial AS; Mauran PL; Sulmont V; Doco-Fenzy M; Rivolta CM
    Clin Endocrinol (Oxf); 2010 May; 72(5):716-8. PubMed ID: 20447071
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of PENDRIN (SLC26A4) mutations in patients with congenital hypothyroidism and "apparent" thyroid dysgenesis.
    Kühnen P; Turan S; Fröhler S; Güran T; Abali S; Biebermann H; Bereket A; Grüters A; Chen W; Krude H
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E169-76. PubMed ID: 24248179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the Clinical Spectrum Associated With GLIS3 Mutations.
    Dimitri P; Habeb AM; Gurbuz F; Millward A; Wallis S; Moussa K; Akcay T; Taha D; Hogue J; Slavotinek A; Wales JK; Shetty A; Hawkes D; Hattersley AT; Ellard S; De Franco E
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1362-9. PubMed ID: 26259131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A locus on mouse chromosome 2 is involved in susceptibility to congenital hypothyroidism and contains an essential gene expressed in thyroid.
    Amendola E; Sanges R; Galvan A; Dathan N; Manenti G; Ferrandino G; Alvino FM; Di Palma T; Scarfò M; Zannini M; Dragani TA; De Felice M; Di Lauro R
    Endocrinology; 2010 Apr; 151(4):1948-58. PubMed ID: 20160132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Activating Mutation in
    Velayos T; Martínez R; Alonso M; Garcia-Etxebarria K; Aguayo A; Camarero C; Urrutia I; Martínez de LaPiscina I; Barrio R; Santin I; Castaño L
    Diabetes; 2017 Apr; 66(4):1022-1029. PubMed ID: 28073828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein A30P decreases neurodegeneration and increases synaptic vesicle release probability in CSPα-null mice.
    Ruiz R; Biea IA; Tabares L
    Neuropharmacology; 2014 Jan; 76 Pt A():106-17. PubMed ID: 24036317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes in the family of subjects with congenital hypothyroidism.
    Menzinger G; Fallucca F; Tamburrano G; Pinchera A; Javicoli M; Andreani D
    Folia Endocrinol; 1970 Oct; 23(5):497-503. PubMed ID: 5537820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.